Please login to the form below
public health
This page shows the latest public health news and features for those working in and with pharma, biotech and healthcare.
Behaviour change theory
Traditionally, health systems have taken a didactic approach, with public health interventions having limited success. ... This is a big missed opportunity. Successful public health campaigns involve large numbers of people from a wide range of
Latest news
-
One dose of AZ’s COVID-19 vaccine ‘highly effective’ against severe disease from variants
Another study, from Public Health England (PHE), found earlier this week that two doses of the AZ vaccine or the Pfizer/BioNTech vaccine could protect against symptoms caused by the Alpha
-
Pfizer, BioNTech eye US approval for COVID-19 booster dose
Recently published findings from Israel’s Health Ministry suggests that Pfizer/BioNTech’s COVID-19 vaccine is less effective against the Delta variant. ... Additional data from a study conducted by Public Health England (PHE) found that the
-
UK to provide genomic sequencing globally to identify COVID-19 variants
Public Health England has identified the first group of countries to receive genomic sequencing support through NVAP. ... Public Health England (PHE) has identified the first group of countries to receive COVID-19 genomic sequencing support as part of
-
Moderna launches phase 1/2 study of mRNA-based flu vaccine
It will target the lineages recommended by the World Health Organization (WHO) for the prevention of flu, including seasonal influenza A H1N1, H3N2 and influenza B Yamagata and Victoria. ... We look forward to advancing our core modality of prophylactic
-
Israel study suggests Pfizer/BioNTech vaccine is less effective against Delta variant
Earlier this year, the Israeli Health Ministry found the Pfizer/BioNTech vaccine to be 94% effective after two doses. ... A study from Public Health England (PHE) also recently suggested that two doses of either Pfizer/BioNTech or AstraZeneca’s (AZ)
One dose of AZ’s COVID-19 vaccine ‘highly effective’ against severe disease from variants
Pfizer, BioNTech eye US approval for COVID-19 booster dose
UK to provide genomic sequencing globally to identify COVID-19 variants
Moderna launches phase 1/2 study of mRNA-based flu vaccine
Israel study suggests Pfizer/BioNTech vaccine is less effective against Delta variant
More from news
Approximately 87 fully matching, plus 911 partially matching documents found.
Latest Intelligence
-
To avoid making mistakes when applying behavioural insights in healthcare, we need to understand why people do what they do
campaigns. Governments and public health bodies are now routinely and openly employing behavioural science to improve the health of their populations.
-
Patient-centred drug development: how far have we come and what’s next?
then we can make a more meaningful difference to the way we conduct the business of drug development, run our studies, engage with the public and, ultimately, patient experiences and health ... Jo Fearnhead-Wymbs is Vice President, Patient Engagement at
-
Healthcare communications – adapting to ‘the new normal’
Policymakers, media and the public all interacted on health issues, changing the shape and pattern of communications. ... COVID-19 was creating a framework for a far more efficient transmission of public health messaging, not just in infectious disease,
-
The AMR Action Fund is combating antimicrobial resistance, but much more action is needed
While this makes sense for public health, it doesn’t support the level of investment needed to maintain a robust antibiotic pipeline – which has contributed to our current predicament. ... The AMR Action Fund is a broad alliance of industry and
-
Fair representation in research matters to the sector and to society
During COVID-19 they have played a critical role supporting communities and disseminating public health messages. ... Alongside this, because of COVID-19, public awareness of health research and trials, and health equity and justice is at an all time high
To avoid making mistakes when applying behavioural insights in healthcare, we need to understand why people do what they do
Patient-centred drug development: how far have we come and what’s next?
Healthcare communications – adapting to ‘the new normal’
The AMR Action Fund is combating antimicrobial resistance, but much more action is needed
Fair representation in research matters to the sector and to society
More from intelligence
Approximately 2 fully matching, plus 145 partially matching documents found.
Latest appointments
-
ENGINE MHP+Mischief bolsters healthcare comms expertise with new senior hires
Prior to joining ENGINE MHP Mischief, Mohamed worked as the chief press officer for international, public health and medicines policy at the Department for Health and Social Care. ... The last year has once again underscored the importance of
-
Hanover Health appoints two new associate directors
Donna Curran joins the communications team and Mark MacDonald joins the public affairs practice. ... Hanover Health has announced two new senior appointments, with Donna Curran and Mark MacDonald joining the company as associate directors.
-
akt health communications hires Heather Tarplee as senior account director
Prior to joining akt health, Tarplee worked at Freuds for a period of five years. ... Tarplee brings significant healthcare PR experience to akt health, including in leading large teams to deliver national health campaigns for public sector clients, such
-
New hire and promotions announced at Evoke KYNE
Karen Urban joins Evoke as a vice president. Health communications agency Evoke KYNE has promoted Sarah Cooper Welty to senior vice president. ... Urban brings more than a decade of health-focused public relations experience to Evoke KYNE.
-
NICE looks internally for new chief executive
Leng has been deputy chief executive at NICE since 2007 and is also currently the agency’s director of health and social care. ... Originally training in medicine, Leng went on to work on clinical trials and epidemiological research as well as a
ENGINE MHP+Mischief bolsters healthcare comms expertise with new senior hires
Hanover Health appoints two new associate directors
akt health communications hires Heather Tarplee as senior account director
New hire and promotions announced at Evoke KYNE
NICE looks internally for new chief executive
More from appointments
Approximately 3 fully matching, plus 69 partially matching documents found.
Latest from PMHub
-
CHANGING FACES: UNDERSTANDING THE KEY CUSTOMER CONTACT POINTS WITHIN THE ICS LANDSCAPE
Another key component will be the ICS Partnership Committee, also sometimes called the Health and Care Partnership board. ... The ICS Partnership Committee won’t be a statutory body, but should be made up of equal representation from local government
-
Will most electronic consumer goods turn into medical devices after the MDR?
The interaction between general consumer goods and medical software has been a revolutionary development for public health, given the vast number of medical applications that monitor the general public's health ... All devices should be used for their
-
Health literacy in the time of COVID-19
COVID-19 has prompted an interest in microbiology, immunology, epidemiology, and public health never seen on this scale before. ... Further, the authors noted that inconsistent risk messages from public health experts and elected officials may reduce
-
Lucid Group celebrates a double win at Communiqué 2021
EXCELLENCE IN PUBLIC HEALTH COMMUNICATIONS for Insight-led Flu Vaccination Public Activation Campaign: London VaccScene ‘Share the Moment’.
-
Hepatitis (C)an’t wait: taking a de-centralized approach to cure the epidemic
The introduction of direct-acting-antivirals has revolutionized the treatment landscape, leading the World Health Organization to set a global target to eliminate the disease as a public health problem by ... Despite huge advances in the field, the
Will most electronic consumer goods turn into medical devices after the MDR?
More from PMHub
Approximately 6 fully matching, plus 120 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- Home Working Medical Copy Writer & Senior Medical Copy Write...
-
Highly Competitive Salary, Bonus &Benefits
- Account Director, Medical & Brand Communications, London/ SE...
-
Highly competitive salary
- Freelance Scientific Director, Medical Communications, London/ S...
-
Highly competitive salary
- Senior Account Management Trainer, Medical Communications, Londo...
-
Highly competitive salary
- Senior Account Director, Medical & Brand Communications, Lon...
-
Highly competitive salary
- Editorial Director - UK, , EUROPE, REMOTE.
-
Highly Competitive Salary, Bonus &Benefits
- Medical Writers (All levels) Editorial / Scientific Leads & ...
-
Highly Competitive Remuneration packages
- EU “still interested” in Valneva COVID vaccine despite UK snub
- US demand for COVID-19 antibody treatments rising fast
- Merck’s anti-COVID drug molnupiravir moves to phase 3 for prevention
- First oral antiviral drug for COVID-19 reviewed by Health Canada
- One dose of AZ’s COVID-19 vaccine ‘highly effective’ against severe disease from variants
- AstraZeneca’s Imfinzi provides sustained survival benefit for lung cancer patients
- Live Webinar: Artificial Intelligence for Improving Patient Outcomes & Operational Efficiency
- CHANGING FACES: UNDERSTANDING THE KEY CUSTOMER CONTACT POINTS WITHIN THE ICS LANDSCAPE
- FDA approves Seagen/Genmab’s antibody-drug conjugate Tivdak for women with advanced cervical cancer
- AstraZeneca chooses Ireland for $360m manufacturing site
- Building the perfect behaviour-change buffet
- Live Webinar: Making Actionable Health Information More Accessible Through Point-of-Care Testing
- FDA’s director and deputy director of its Office of Vaccines Research & Review resign
- Live Webinar: Making Actionable Health Information More Accessible Through Point-of-Care Testing
- David Hunt launches independent agency The Considered
- Lucid Group celebrates a double win at Communiqué 2021
- Live Webinar: Driving Healthcare Decisions with Natural Language Processing
- US orders 1.4 million more doses of Regeneron antibody cocktail
PMHub
Havas Lynx Group
We are the Havas Lynx Group. Devoted to fresh thinking. Changing the way the world does healthcare communications for the...
Latest intelligence
- Robust Review: COVID19 Assessment
- See how our client utilized Rapid Payer Response (RPR) to stay informed and gain continuous insights during the recent global pandemic (COVID19)...
- All change – how untangling human behaviour can encourage better health
- Driving better patient outcomes through clear, achievable practical steps that are underpinned by transparent evidence...
- Health literacy in the time of COVID-19
- In a time when much of the media’s focus is on the ongoing COVID-19 pandemic and the differences in vaccination rates between various regions, countries, and socioeconomic groups, improving health...
